[1]
Khalaf, D.J. et al. 2017. A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Canadian Urological Association Journal. 12, 2 (Dec. 2017), E47–52. DOI:https://doi.org/10.5489/cuaj.4600.